Matthew Hill, PhD

Matt Hill is driven by a mission to create a lasting positive impact on the world. He holds a PhD in Genetics from Stanford, and was previously Vice President of Research and Development at Natera where he co-invented their core technology and led the commercialization of five precision molecular diagnostic products. This included Natera’s best-in-class noninvasive prenatal test, which has been used by millions to ensure healthy pregnancies, and which enabled Natera’s 2015 IPO. He founded Elegen to solve DNA writing and unlock the synthetic biology revolution.